Cancer Therapy Market by Therapy Type (Chemotherapy, Hormonal Therapy, Immunotherapy, Radiation Therapy, Stem Cell Transplant, Targeted Therapy, Others), Disease Type (Breast Cancer, Hematological Malignancy, Prostate Cancer, Pulmonary Cancer, Skin Cancer, Others) and Forecast 2017-2021

Cancer Therapy Market by Therapy Type (Chemotherapy, Hormonal Therapy, Immunotherapy, Radiation Therapy, Stem Cell Transplant, Targeted Therapy, Others), Disease Type (Breast Cancer, Hematological Malignancy, Prostate Cancer, Pulmonary Cancer, Skin Cancer, Others) and Forecast 2017-2021

There are many types of cancer therapies based on the type and development stage of cancer. Chemotherapy is a type of cancer treatment that uses drugs to kill cancer cells. It is used to treat many types of cancer, however can cause damage to many growing cells, including some healthy cells. Hormone therapy or endocrine therapy is a treatment that slows or stops the growth of breast and prostate cancers that use hormones to grow. Immunotherapy is a type of cancer treatment that helps your immune system fight cancer. Radiation therapy is a type of cancer treatment that uses high doses of radiation to kill cancer cells and shrink tumors. Stem cell transplants are procedures that restore blood-forming stem cells in cancer patients who have had theirs destroyed by very high doses of chemotherapy or radiation therapy. Targeted therapy is a type of cancer treatment that targets the changes in cancer cells that help them grow, divide, and spread.

The global cancer therapy market segmentation is based on therapy type (chemotherapy, hormonal therapy, immunotherapy, radiation therapy, stem cell transplant, targeted therapy, others), and disease type (breast cancer, hematological malignancy, prostate cancer, pulmonary cancer, skin cancer, others).

The global cancer therapy market report provides market size (Revenue US$ Million 2014 to 2021), market share, trends and forecasts growth trends (CAGR%, 2017 to 2021). The global cancer therapy market research report is further segmented by geography into North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), Latin America (Brazil, Mexico, Rest of LA), and Rest of the World. The global cancer therapy market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and also tracks the major competitors operating in the market by company overview, financial snapshot, key products, technologies and services offered, market share analysis and recent trends in the global market.

Major players operating in the global cancer therapy market and profiled in this report include Amgen, Inc., Celgene Corporation, GlaxoSmithKline PLC, Johnson and Johnson, Merck & Co., Inc., Novartis, Pfizer, Inc., and Roche Holdings.

Category:
  1. Introduction
  2. Executive Summary
    • Market Size Estimation (Revenue US$ Million, 2014-2021)
    • Forecast Estimation (Revenue US$ Million and CAGR%, 2017-2021)
  3. Research Methodology
  4. Market Landscape
    • Market Dynamics
      • Drivers
      • Barriers
      • Opportunities
    • Market Share Analysis
      • Companies
      • Drugs
    • Market Trends Analysis
      • Key success factors
      • Market Growth Rate
    • Market Attractiveness Analysis
    • Market Profitability Analysis
      • Buyer power
      • Supplier power
      • Barriers to entry
      • Threat of substitute products
      • Rivalry among firms in the industry
    • Distribution Channels
  5. Market Segmentation [refer Market Segments and Companies Tab]
    • Drug Class or Drug (Brand) Type
    • Drug or Disorder Test
    • Indication Type
    • Drug Treatment
    • Mechanism of Action
    • Therapeutic Area or Nature of Application
    • End User Groups
  6. Geography (Region, Country)
    • North America (U.S., Canada)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Rest of the World (Middle East & Africa)
  7. Regulatory Overview 
    • IND, NDA filed, FDA, EMEA Approvals
  8. Pipeline Analysis(Phase 1, 2 and 3 Drugs)
    • Phase 3 Drugs Forecast Estimation (Approval to 2025)
    • Phase 1 and 2 Drugs – Qualitative Analysis
  9. Company Profiles [refer Market Segments and Companies Tab]
    • Company Overview
    • Financial Snapshot (FY 2014-2016)
    • Product Portfolio
    • Business Strategies
    • Recent Developments
  10. Recommendations
  11. References

Cancer Therapy Market

1. Therapy Type
1.1. Chemotherapy
1.2. Hormonal Therapy
1.3. Immunotherapy
1.4. Radiation Therapy
1.5. Stem Cell Transplant
1.6. Targeted Therapy
1.7. Others

2. Disease Type
2.1. Breast Cancer
2.2. Hematological Malignancy
2.3. Prostate Cancer
2.4. Pulmonary Cancer
2.5. Skin Cancer
2.6. Others

3. Geography (Region, Country)
3.1. North America (U.S., Canada)
3.2. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
3.3. Latin America (Brazil, Mexico, Rest of LA)
3.4. Asia Pacific (Japan, China, India, Rest of APAC)
3.5. Rest of the World (Middle East & Africa)

4. Company Profiles
4.1. Amgen, Inc.
4.2. Celgene Corporation
4.3. GlaxoSmithKline PLC
4.4. Johnson and Johnson
4.5. Merck & Co., Inc.
4.6. Novartis
4.7. Pfizer, Inc.
4.8. Roche Holdings

Request market specific full ToC and sample pages for this report

Full Name*

Email*

Phone Number* [Please add country code]

Subject*

Message*